Stay updated on Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.

Latest updates to the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page
- Check5 days agoChange DetectedNew help and navigation sections were added to improve reader access to study information, including How to Read a Study Record, Common Questions, and How to Join a Study. The page now shows an updated revision tag (Revision: v3.6.0) and standardizes the Intervention/Treatment label, replacing the previous Interventions / Treatment formatting and removing the older revision tag.SummaryDifference0.2%

- Check13 days agoChange Detected- Revision updated from v3.5.4 to v3.5.5, indicating a small metadata update to the page.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedNew update dates were added (2026-05-21 and 2026-05-22) and older dates (2026-05-12, 2026-05-13, and 2025-11) were removed from the Study Record Dates, reflecting recent administrative updates to the page.SummaryDifference0.1%

- Check34 days agoChange DetectedA new Sample Collection section was added to the study plan, and the record was updated to revision v3.5.4, signaling changes in how specimens are collected and documented for the trial.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page footer revision identifier was updated from v3.5.2 to v3.5.3, reflecting a site versioning change rather than a change to the clinical trial information.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.